Top

States Try to Obscure Execution Details as Drugmakers Hinder Lethal Injection

Merck signs $922m deal with Opko Health unit for Epstein-Barr vaccine candidate

After Capping Insulin Copays, Colorado Sets Its Sights on EpiPens

Almond, Soy Drinks Can Be Called Milk, FDA Proposes

GSK and Vir Biotech amend COVID-19 research partnership

Tag: Arcus

Industry, Pharma

Gilead pays up to retain rights to Arcus cancer drugs

November 18, 2021

Via: Biopharma Dive

The initial deal between Gilead and Arcus gave the larger drugmaker rights to an experimental drug called zimberelimab, which attacks cancers using the same mechanism as Keytruda, along with an option to license the four projects covered by Thursday’s announcement. […]